North America Benign Prostatic Hyperplasic Devices Market Size, Historical Growth, Analysis, Opportunities and Forecast To 2028

The benign prostatic hyperplasic devices market in North America is expected to grow from US$ 863.12 million in 2022 to US$ 1,349.19 million by 2028; it is estimated to grow at a CAGR of 7.7% from 2022 to 2028.

Benign prostatic hyperplasia (BPH) is a prostate enlargement caused by excessive cell growth in the prostate. This noncancerous prostate condition is usually not fatal. Being benign, the condition does not involve metastasis to other body parts. BPH is not associated with the risk of prostate cancer; moreover, unless it manifests symptoms, BPH isn't considered a health issue. Almost all men are likely to have some prostate growth by the time they turn 70. Aging, abdominal obesity, and insufficient physical exercise raise the risk of developing BPH. According to the National Center for Biotechnology Information (NCBI), BPH is one of the most common disorders in older men and the leading cause of lower urinary tract symptoms (LUTS). After the age of 40, the prevalence of BPH rises, reaching a peak of 60% by the age of 90. Many autopsy studies suggest that the histological prevalence of BPH is 8%, 50%, and 80% in the fourth, sixth, and ninth decades of the life of a man, respectively. Old age has also been shown to be a risk factor for the onset and progression of clinical BPH in observational studies conducted in the US.

Get a Sample PDF of report at-

https://www.businessmarketinsights.com/sample/BMIRE00027169

Top Key Players Listed in the North America Benign Prostatic Hyperplasic Devices Market 2022 - 2028 Report Are:

KARL STORZ SE & Co. KG
Olympus Corporation
Boston Scientific Corporation
Teleflex Incorporated
Richard Wolf GmbH
Urologix, LLC.
OmniGuide Holdings, Inc.
Convergent Laser Technologies
In this report, the market has been segmented on the basis of:

The North America benign prostatic hyperplasic devices market is segmented on the basis of product, procedure type, end user, and country. Based on product, the market is segmented into resectoscopes, urology lasers, radiofrequency ablation devices, prostatic stents, and implants. The resectoscopes segment is expected to hold the largest share of the market in 2022. On the other hand, the urology lasers segment is expected to register the highest CAGR during the forecast period.

Based on procedure type, the North America benign prostatic hyperplasic devices market is segmented into transurethral microwave therapy, transurethral resection of the prostate, transurethral needle ablation of the prostate, laser surgery, urolift surgery, and others.

The transurethral resection of the prostate segment held the largest market share in 2022, and it is also expected to register the highest CAGR in the market during the forecast period. Based on end user, the North America benign prostatic hyperplasic devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospital segment held the largest market share in 2022, while the clinics segment is expected to register the highest CAGR during the forecast period.

The North America Benign Prostatic Hyperplasic Devices Market 2022 - 2028 Competitive Viewpoint:

This analysis is a useful resource for investors, shareholders, industry planners, and new and existing businesses trying to broaden their reach within the current Market situation. While focusing on top companies and their corporate strategies, market presence, operative segmentation, aggressive outlook, geographical growth, pricing and price structures, the study painstakingly takes into consideration the market analysis.

Get Full North America Benign Prostatic Hyperplasic Devices Market Report :https://www.businessmarketinsights.com/reports/north-america-benign-prostatic-hyperplasic-devices-market

Reason to buy this report:

• Understand the Current and future of the North America Benign Prostatic Hyperplasic Devices Market in both Established and rising markets.
• The report enlightens the massive patterns, causes, and impact factors globally and regionally.

• The latest developments within the North America Benign Prostatic Hyperplasic Devices market and details of the industry leaders alongside their market share and methods.
• It looks into vital developments like extensions, agreements, new product launches, and acquisitions on the horizon.
• Analysis the market's potential, preferred position, opportunity, difficulty, restrictions, and hazards on a world and regional level.

Customized Analysis report:

Click Here to Buy Now:

https://www.businessmarketinsights.com/buy/single/BMIRE00027169

We offer clients specialized report services that take into consideration the most variables influencing the development of the worldwide Market. Feel free to call or drop your requirement to get the get customized research report.

Contact Us:

If you have any questions about this report or would like further information, please contact us:

Contact person: Sameer Joshi

Email: sales@businessmarketinsights.com

Phone: +16467917070

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

This release was published on openPR.